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Background: A unique Glu(2.50) in the NK1 
receptor interacts directly with Ser(3.39) and 
Asn(7.49). 
Results: Mutational changes in this interface 
create receptors which selectively signal through 
Gq or -arrestin versus Gs. 
Conclusion: Identification of a focal point in 
differentiation between Gs, Gq and -arrestin 
signaling. 
Significance: This network constitutes an 
allosteric interface essential for 7TM receptor 
fine-tuning towards different signaling 
pathways. 
ABSTRACT 
X-ray structures, molecular dynamics 
simulations and mutational analysis have 
previously indicated that an extended water 
hydrogen-bond network between TM-I, -II, -
III, -VI and -VII constitutes an allosteric 
interface essential for stabilizing different 
active and inactive helical constellations 
during 7TM receptor activation. The NK1 
receptor signals efficiently through Gq, Gs 
and -arrestin when stimulated by substance 
P, but lacks any sign of constitutive activity. 
In the water hydrogen-bond network the NK1 
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has a unique Glu residue instead of the highly 
conserved AspII:10 (2.50). Here we find that 
this GluII:10 occupies the space of a putative 
allosteric modulating Na
+
 ion and makes 
direct inter-helical interactions in particular 
with SerIII:15 (3.39) and AsnVII:16 (7.49) of 
the NPxxY motif. Mutational changes in the 
interface between GluII:10 and AsnVII:16 
created receptors which selectively signaled 
through: 1) Gq only, 2) -arrestin only; and 
3) Gq and -arrestin but not through Gs. 
Interestingly, increased constitutive Gs but 
not Gq signaling was observed by Ala-
substitution of four out of the six core polar 
residues of the network - in particular 
SerII:15. Three residues were essential for all 
three signaling pathways, i.e. the water-gating 
micro-switch residues TrpVI:13 (6.48) of the 
CWxP motif and TyrVII:20 (7.53) of the 
NPxxY motif plus the totally conserved 
AsnI:18 (1.50) stabilizing the kink in TM-VII. 
It is concluded that the interface between 
position II:10 (2.50), III:15 (3.39), and VII:16 
(7.49) in the center of the water hydrogen-
bond network constitutes a focal point for 
fine-tuning 7TM receptor conformations 
activating different signal transduction 
pathways 
Within the last decade, high resolution X-ray 
structures of a large number of family A seven 
trans-membrane (7TM)1, G protein-coupled 
receptors have underlined the association 
between highly conserved residues in the 
transmembrane segments and receptor function 
(1-4). These conserved residues are in particular 
located in the intracellular parts of the 
transmembrane helices where they function 
either as micro-switches, or are involved in the 
large water-mediated hydrogen-bond network. 
This network constitutes an extended allosteric 
interface between the helices which perform the 
large-scale movements when the receptor 
alternates between inactive and active 
conformations (2,5). The water-mediated 
hydrogen-bond network is limited at the extra-
cellular side by TrpVI:13 (6.48)2 of the so-called 
CWxP motif in the middle of TM-VI, which 
forms the ‘gate’ between the network and the 
extracellular facing ligand-binding pocket (2). 
At the cytoplasmic side the network is limited by 
TyrVII:20 (7.53), which is part of the NPxxY 
motif at the intracellular end of TM-VII (Fig. 
1A). Previously, by use of molecular dynamics 
simulations and molecular pharmacological 
means we have presented evidence indicating 
that key polar residues of this interface are 
essential for the signal-transduction process in 
the 2-adrenergic receptor (B2AR) and that 
TrpVI:13 (6.48) and TyrVII:20 (7.53) appear to 
function as gates for the movements of water 
molecules in and out of the network (5).   
The polar residues of the water hydrogen-bond 
network are not only highly conserved in the 
primary structure (Fig. 1D), but are also almost 
superimposable in all the other twenty unique 
inactive X-ray structures (Fig. 1A) solved to date 
(6-26). Surprisingly, the structures revealed that 
in the inactive state almost no hydrogen-bonds 
are observed between the polar residues 
themselves. Instead, they interact through a 
number of structural water molecules generating 
the extended hydrogen-bond network as shown 
for the inactive adenosine A2A receptor (A2AAR) 
and B2AR structures in figure 1A-C (10,16). 
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Interestingly, a sodium ion was identified as an 
important part of this network located almost 
identically in the A2AAR, the protease-activated 
receptor 1 and most recently in the 1.8 Å high-
resolution structure of the -opioid receptor 
(12,26-28). In these structures, the sodium ion is 
coordinated by the highly conserved AspII:10 
(2.50) in TM-II and SerIII:15 (3.39) in TM-III, 
besides nearby water molecules in a position 
previously shown to be taken up by either 
structural water molecules or left as a relatively 
large ‘empty space’ in X-ray structures of 
inactive forms of other 7TM receptors(28). 
Importantly, in the active structure of the B2AR 
and the active-like structures of the A2AAR, this 
region has undergone major conformational 
changes including the well-recognized major 
tilts of the intracellular parts of TM-V (inward) 
and TM-VI (outward) combined with an inward 
tilt of TM-VII (more than 2 Å combined with 
rotation), and an axial shift of TM-III (29,30). 
These movements eliminate much of the space 
occupied by water and the sodium ion in the 
inactive conformation so that in the active state 
the polar residues instead mainly make 
hydrogen-bonds directly with each other (Fig. 
1C). The notion that a sodium ion stabilizes the 
inactive conformation of 7TM receptors, and 
acts as negative allosteric modulators was well-
established 1½ decade ago through studies of, 
for example the 2a adrenergic receptor, the 
A2AAR, the µ- and -opioid receptors, and the 
D2 dopamine receptor (31-37). However, we 
now have structural proof of this interaction in 
the A2AAR and the -opioid receptor, which 
provides a detailed picture of how other residues 
besides AspII:10 (2.50) - in particular SerIII:15 
(3.39) - also are involved in the binding of the 
allosteric negative regulator Na+ (16,27,30).  
In the present study we investigate the relative 
role of different residues in the conserved polar 
interface in the neurokinin-1 (NK1) receptor, 
which is activated by substance P and signals 
through both the Gq and the Gs pathway (38-41). 
A unique structural feature of the NK1 receptor 
is a glutamic acid residue in position II:10 
(2.50), in contrast to aspartic acid found in more 
than 98% of other family A receptors (42). 
Interestingly, the unstimulated NK1 receptor is 
very ‘silent’ with no evidence of constitutive 
activity resulting from spontaneous transition to 
the active state. For more than two decades we 
have performed structure-functional studies on 
the NK1 receptor and have never observed 
measurable constitutive activity and in contrast 
to most other 7TM receptors, we have never 
identified an NK1 mutant showing ligand-
independent signaling (38,43-47). This is 
particularly surprising as it is generally known in 
the field that it is rather easy to find mutations in 
7TM receptors which make them signal with 
high constitutive activity.  
We now find that in molecular models of the 
NK1 receptor the gamma-carboxylic acid group 
of the larger GluII:10 (2.50) side-chain 
(compared to Asp) is located at or very close to 
the position where the negative allosteric 
modulating sodium ion is found in for example 
the A2AAR, the -opioid receptor and the 1-
adrenergic receptor (27,28,32,48) and that it 
makes direct hydrogen-bonds to other members 
of the water-hydrogen-bond network, SerIII:15 
(3.39) and AsnVII:16 (7.49). Mutational analysis 
indicates that GluII:10 and its two hydrogen-
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bond partners in different ways are involved in 
tuning Gs versus Gq and -arrestin signaling and 
that negative modulatory Na+ effects could be 
induced in the NK1 receptor by ‘reintroducing’ 
Asp in position II:10.  
Experimental procedures 
Comparative homology modelling - The 
sequence of the human NK1 receptor was 
obtained at the Uniprot webpage. The distinct X-
ray structures (available at the time the modeling 
were conducted) of 7TM receptors in inactive 
like states: adenosine A2A (4EIY), 1-adrenergic 
receptor (2VT4), 2-adrenergic receptor (2RH1), 
chemokine CXCR4 (3ODU), chemokine CCR5 
(4MBS), dopamine D3 (3PBL), Histamine H1 
(3RZE), Muscarinic M2 (3OUN) Muscarinic M3 
(4DAJ), Serotonin 5HT1B (4IAR), Serotonin 
5HT2B (4IB4), µ-opioid (4DKL) -opioid 
(4EJ4), k-opioid (4DJH), Nociceptin (4EA3), 
protease-activated receptor 1 (3VW7), 
Sphingosine S1P (3V2Y) and rhodopsin 
(1GZM) as well as the structures in active like 
states: adenosine A2A (3QAK), 2-adrenergic 
receptor (3SN6), Muscarinic M2 (4MQS), 
Neurotensin 1 receptor (4GRV) were obtained 
from the PDB database. The structures were 
superimposed with respect to the intracellular 
half of TM-I, -II, -III and –VII using the 
CEAlign protocol in Pymol. Pairwise sequence 
alignments and comparative homology models 
(excluding intra- and extracellular loops) of the 
NK1 receptor were produced in ICM 3.7b using 
the in-active and active like structures of A2AAR 
and B2AR as templates which devised 
reasonable high sequence identity to the 
intracellular half of TM-I, -II, -III and –VII. 
GluII:10 was assumed to be negatively charged 
as it is located in-between SerIII:15 and 
ThrVII:13 in an optimal position to be involved 
in hydrogen-bond interactions the hydroxyl side-
chain of SerIII:15 and the co-existence of 
“conserved” bulky water molecules observed in 
other receptors with similar environments. 
Initially, hydrogen atoms and side-chains were 
optimized using the comparative modeling 
protocol in ICM. When modeling the inactive 
state of NK1R, the sodium ion and structural 
water molecules of the template structures were 
“copied” to the comparative NK1 receptor 
models. The location of the sodium ion and 
water molecules was initially accessed in the 
presence of a fixed NK1 receptor model. The 
sodium ion and a nearby water molecule, which 
are involved in hydrogen bond interaction with 
AspII:10 and SerIII:15 in the parent A2AAR and 
B2AR structures were removed from the NK1 
receptor models as they make steric clashes with 
the larger (compared to Asp) carboxyl acid side-
chain of GluII:10 in the NK1 receptor models. 
Local optimization of side-chains within 8 Å of 
this co-localized sodium ion/water molecule was 
unable to release the strain when optimizing all 
atoms using the biased probability Monte Carlo 
optimization protocol (200 global moves and 
100 local minimization calls). To ensure 
acceptance of the remaining water molecules, 
side-chains and water molecules were globally 
optimized using the Monte Carlo conformational 
sampling procedure in the presence of a fixed 
main chain conformation in ICM 3.7b. Finally, 
the resulting NK1 models were minimized in 
300 steps of steepest decent, using the MMFF 
force field and all atoms were free to move. In 
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the present work we only present the NK1 
receptor model based on A2AAR as the 
corresponding NK1 receptor model based on 
B2AR are highly similar.  
Materials- Substance P and ghrelin were 
purchased from Bachem and [125I]Lys3]-SP from 
Perkin Elmer. Pindolol was purchased from 
Sigma and AR-231453 was a generous gift from 
Arena Pharmaceuticals (San Diego, USA) 
Molecular Biology- The NK1, B2AR and 
GHSR cDNA was cloned into the eukaryotic 
expression vector pCMV-Tag (2B) (Stratagene) 
while GPR119 cDNA was cloned into the 
pcDNA3.1 vector (Invitrogen). Mutations were 
constructed by PCR using the Quick Change 
method. All PCR experiments were performed 
using Pfu polymerase (Stratagene) according to 
the instructions of the manufacturer. All 
mutations were verified by DNA sequence 
analysis by MWG (Ebersberg, Germany). For -
arrestin recruitment cDNAs encoding native and 
mutant NK1 receptors were tagged at the C 
terminal with an enzyme donor fragment of -
galactosidase.  
Transfections and Tissue Culture-COS-7 cells 
were grown in Dulbecco’s modified Eagle’s 
medium 1885 supplemented with 10% fetal calf 
serum, 2mM glutamine, 100U/ml Penicillin and 
100g/ml streptomycin. Cells were transfected 
with 20g/75cm2 of DNA using the calcium 
phosphate precipitation method with chloroquine 
addition as previously described (45). 
CHO-K1 cells stably expressing -arrestin2 
tagged with the enzyme accepting portion of an 
-galactosidase enzyme were grown in 
HAMF12 media supplemented with 10% fetal 
calf serum, 2mM glutamine, 100U/ml Penicillin, 
100g/ml Streptomycin and 300g/ml of 
Hygromycin. Cells were transfected using 
0.15µl fuGENE (Promega,WI,USA)/well in 
opaque white 96-well plates using 50ng 
DNA/well according to the manufacturer’s 
protocol. 
Cell surface expression (ELISA)-Cells 
transfected and seeded for IP3 or cAMP were in 
parallel seeded for ELISA. The cells were 
washed twice with 200µl phosphate buffered 
saline (PBS), fixed with 150µl 
paraformaldehyde for 10 min and finally 
incubated in blocking solution (PBS plus 3% dry 
milk) for 30 min at room temperature. 
Subsequently the cells were incubated 1 hour at 
room temperature with anti-FLAG (M2) (Sigma) 
antibody diluted 1:1000. The cells were washed 
3 times with PBS and incubated 1 hour at room 
temperature with anti-mouse horseradish 
peroxidise conjugated antibody (Sigma) diluted 
1:1250. After 3 additional washing steps with 
PBS immunoreactivity were discovered by 
addition of horseradish peroxidise. The 
absorbance was read on the Topcount (Perkin 
Elmer). 
Competition Binding Assay – Transfected COS-
7 cells were plated in poly-D-lysine coated 96-
well plates at a density of 500-20,000 cells/ well 
aiming at 5-10% binding of the radioactive 
ligand. The following day the binding 
experiments were performed for 3 hours at 4ºC 
using ~25pM 125I-SP (Perkin Elmer). Binding 
assays were performed in 0.1ml of a HEPES 
buffer, pH 7.4, supplemented with 1mM CaCl2, 
5mM MgCl2, 0.1% (w/v) bovine serum albumin 
and 40µg/ml bacitracin with or without 
increasing concentrations of NaCl. Nonspecific 
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binding was determined as the binding in the 
presence of 1µM unlabelled SP. After two 
washes in cold buffer, Lysis buffer (1% SDS, 
200mM NaOH) was added for 30 min and 
radioactivity was counted.  
Phosphatidylinositol Turnover Assay-One day 
after transfection, COS-7 cells were incubated 
for 24 h with 5Ci of [3H]myo-inositol (catalog 
number PT6–271, Amersham Biosciences) in 
300l of medium supplemented with 10% fetal 
calf serum, 2mM glutamine, 100U/ml Penicillin 
and 100g/ml streptomycin per well. Cells were 
washed twice in 20mM HEPES buffer (pH 7.4, 
supplemented with 140mM NaCl, 5mM KCl, 
1mM MgSO4, 1mM CaCl2, 10mM glucose, 
0.05% (w/v) fetal bovine serum), and following 
incubated in 0.2ml of HEPES buffer 
supplemented with 10mM LiCl at 37 °C for 15 
min. After stimulation with SP for 45min at 37 
°C, cells were extracted with 10mM formic acid 
followed by incubation on ice for 30 min. The 
resulting supernatant was purified on Bio-Rad 
AG 1-X8 anion exchange resin to isolate the 
negatively charged inositol phosphates. After 
application of the cell extract to the column, the 
columns were washed twice with GPI buffer 
(60mM sodium formate and 100mM formic 
acid) to remove glycerophosphoinositol. Inositol 
phosphates were eluded by the addition of 
elution buffer (1mM ammonium formate, 
100mM formic acid). Determinations were made 
in duplicates. The columns containing AG 1-X8 
anion exchange resin were regenerated by the 
addition of 3ml of regeneration buffer (3M 
ammonium formate, 100mM formic acid) and 
10ml of water. 
cAMP Assay-One day after transfection COS-7 
cells were plated into white 96-well plates 
(20.000 cells/well). The day after, cAMP assay 
was performed using DiscoveRX HitHunterTM
cAMPxs+ kit (Fremont, CA, USA) according to 
the manufacturer´s protocol. 
-Arrestin2 recruitment-The day after 
transfection -Arrestin2 recruitment was 
determined using DiscoveRX PathHunterR -
Arrestin GPCR Assay (Fremont, CA, USA) 
according to the manufacturers protocol. 
Calculations-EC50 values were determined by 
nonlinear regression using the Prism 6.0 
software (GraphPad Software, San Diego). 
Unpaired t-test (P0.05) was performed using 
the Prism 6.0 software (GraphPad Software, San 
Diego). 
Results 
Modeling of the polar network in the NK1 
receptor 
Analysis of 20 unique inactive 7TM receptor 
structures in complexes with inverse agonists or 
antagonists demonstrated that polar, water- and 
sodium ion-coordinating residues of the 
conserved interface between the intracellular 
segments of TM-I, -II, -III and –VII, can be 
almost perfectly superimposed (Fig. 1A and 1B) 
(7,8,10-21,23-26,49,50). This is in contrast to 
residues in the extracellular ligand-binding 
pocket, which shows larger variations in 
sequence and structure. Although a sodium ion 
has only been directly identified in this polar 
interface of the A2AAR, protease-activated 
receptor 1 and the -opioid receptors, there is 
also clearly room for it, in between the highly 
conserved AspII:10 (2.50) and SerIII:15 (3.39), 
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in all other inactive receptor conformations (37). 
In contrast, in the molecular model of the 
inactive conformation of the NK1 receptor, the 
gamma carboxyl side-chain of GluII:10 replaces 
the sodium ion and/or one or more water 
molecules making direct rather than water-
mediated interactions with not only SerIII:15 
(3.39) but also with AsnVII:16 (7.49) (Fig. 
1E,1F and Fig. 2A). The helix organization and 
side-chain packing of the energy optimized NK1 
receptor models are highly similar to the inactive 
experimental structures when superimposed with 
respect to conserved key residues in the 
intracellular half of TM-I, -II, -III and –VII. 
Either of the water molecules in the refined 
models deviate more than 0.75 Å from their 
original positions and rotamer states of side-
chains involved in the water mediated hydrogen 
bonds remain unchanged. In addition, GluII:10 
(2.50) interacts with TyrVII:20 (7.53) through 
hydrogen-bond interactions with a single water 
molecule, in contrast to the interaction of 
AspII:10 (2.50) with TyrVII:20 (7.53) in the 
inactive structures of A2AAR and B2AR, which 
is mediated through two water molecules 
(5,10,51). 
In the models of the active conformation of the 
NK1 receptor built over the active structures of 
the B2AR-Gs and A2AAR receptors (16,29) the 
volume of the polar interface is greatly reduced 
due to the inward movement of TMVII toward 
TMIII by more than 2Å, which effectively 
‘squeezes’ out the possible sodium ion and most 
of the structural water molecules (Fig. 2A and 
2B). In this model, the carboxylic acid side-
chain of GluII:10 (2.50) could either be making 
direct interactions with SerII:15 (3.39), 
ThrVII:13 (7.46) and AsnVII:16 (7.49) or direct 
interactions with SerIII:15 (3.39) and AsnVII:16 
(7.49) depending on the detailed side-chain 
packing (Fig. 2B). 
In conclusion, the gamma carboxyl side-chain of 
GluII:10 (2.50) in the NK1 receptor appears to 
be substituting the Na+ in the polar interface 
making direct instead of water-mediated 
hydrogen-bond  interactions to other members of 
the hydrogen-bond network (Fig. 2b). 
Functional effects of Ala-substitution of the 
polar residues in the NK1 hydrogen-bond 
network  
The functional importance of each residue in the 
water hydrogen-bond network of the NK1 
receptor was probed by Ala-substitutions and 
constitutive and SP-induced signaling were 
determined for the three different signal 
transduction pathways: 1) Gq signaling 
monitored by IP3 accumulation assay (Fig. 3); 2) 
Gs signaling monitoring by cAMP production 
(Fig. 4); and 3) -arrestin mobilization measured 
by an enzyme complementation assay (Fig. 5). 
The effect of the mutations on cell surface 
expression was determined for each of the 
mutants using cell surface ELISA (inserts in Fig. 
3).  
Effects of Ala-substitutions on Gq signaling 
Ala-substitution of each of the two micro-switch 
residues TrpVI:13 (6.48) of the CWxP motif in 
TM-VI and TyrVII:20 (7.53) of the NPxxY 
motif in TM-VII, which place respective 
extracellular and intracellular limit on the 
hydrogen-bond network eliminated SP-induced 
signalling of the NK1 receptor through the Gq 
pathway as determined by IP3 accumulation 
(Fig. 3h, i and table I). Ala-substitution of the 
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almost 100% conserved AsnI:18 (1.50), which in 
the inactive receptor structures form a direct 
hydrogen bond to the backbone carbonyl group 
of ThrVII:13 (7.46) that is exposed at the helical 
kink in TM-VII (2), also eliminated SP-induced 
Gq signalling (Fig. 3d). Similarly, Ala-
substitution of GluII:10 (2.50) totally eliminated 
SP-induced Gq signalling (Fig. 3c). There was 
no indication of increased constitutive Gq 
signalling in the GluII:10 to Ala mutant receptor 
(Fig. 3c), which otherwise could have been 
expected based on the potential function of 
GluII:10 as a tethered negative allosteric 
regulator as discussed in the molecular 
modelling section above. In TM-VII, Ala-
substitution of SerVII:12 (7.45) impaired the SP-
induced IP3 accumulation down to 35% of the 
Emax observed in the wild-type receptor (Fig. 3f, 
table I). In contrast, Ala-substitution of 
AsnVII:16 (7.49) one helical turn below, which 
we previously found to be essential for Gs 
signalling in the B2AR, had surprisingly almost 
no effect on the SP-induced signalling through 
the Gq pathway in the NK1 receptor (Fig. 3g). 
Similarly, Ala-substitution of ThrVII:13 (7.46) 
and SerIII:15 (3.39) in TM-III located at the top 
of the water hydrogen-bond network had no or 
very little effect on the Gq signalling in the NK1 
receptor (Fig. 3b,e).     
Effects of Ala-substitutions on Gs signaling 
As observed for Gq signaling, Ala-substitution 
of the two water-gating micro-switch residues 
TrpVI:13 (6.48) and TyrVII:20 (7.53) as well as 
Ala-substitution of AsnI:18 (1.50) and GluII:10 
(2.50) eliminated Gs signalling through the NK1 
receptor as measured by SP-induced cAMP 
accumulation and showed no sign of constitutive 
Gs signalling either (Fig. 4h,i,d,c). In contrast, 
increased basal cAMP production in the absence 
of agonist was observed not only in GluII:10 but 
in all of the Ala mutations of the conserved polar 
residues, except for the mutant forms of 
SerVII:12 (7.45) and AsnVII:16 (7.49) (Fig. 4, 
Table I). In particular the SerIII:15 (3.39) to Ala 
mutant showed a highly increased constitutive 
Gs signalling of 37+/-6% of Emax of the wild 
type receptor corresponding to 24% of its own 
somewhat increased Emax (Fig. 4 In case of the 
AsnI:18 and GluII:10 substitutions the SP-
induced cAMP response was totally eliminated 
despite the slightly but significant increased 
basal Gs signalling of the AnsI:18 and GluII:10 
mutants. Surprisingly in view of the lack of 
effect on Gq signaling, removal of the polar 
side-chain of AsnVII:16 (7.49) by Ala-
substitution totally eliminated Gs signalling (Fig. 
3g and 4g), just as we had observed for Ala-
substitution of this residue in the B2AR (5). 
Furthermore, the AsnVII:16 to Ala substitution 
did not increase basal Gs signalling (Fig. 4). 
Effect of Ala-substitutions on -Arrestin 
mobilization 
As shown in Fig. 5, the effects of Ala-
substitution of the residues in the water 
hydrogen-bond network upon -arrestin 
mobilization were rather similar to the effects 
observed in Gq signaling (Fig. 3). Thus, as 
observed in the IP3 assay, Ala-substitution of 
TrpVI:13 (6.48), TyrVII:20 (7.53) and AsnI:18 
(1.50) in all cases eliminated SP-induced -
arrestin mobilization and Ala-substitution of 
ThrVII:13 (7.46) and SerIII:15 (3.39) located at 
the top of the hydrogen-bond network had 
almost no effect or induced a slight increase in 
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-arrestin mobilization. As for IP3 accumulation 
assays, a partial inhibition of the -arrestin 
response was observed following SerVII:12 
(7.46) to Ala mutation (Fig. 5f). In the 
AsnVII:16 (7.49) to Ala mutant, which 
selectively inhibited Gs but not Gq, the -
arrestin response almost similar to the  wild-type  
NK1 receptor was observed (Fig. 5g). 
Interestingly, in the case of GluII:10 (2.50), 
which was totally unresponsive in both Gq and 
Gs signalling, SP responses were evident from 
-arrestin mobilization, albeit only approx. 25% 
of the response observed in the wild type NK1 
receptor (Fig. 5C). 
Effect of substituting GluII:10 with Gln on 
NK1 signaling 
In order to examine the effect of removing the 
potential negative charge of GluII:10 while 
retaining the ability to participate in hydrogen 
bond formation we introduced Gln at this 
position. Cell surface expression of the Gln 
mutant was comparable to WT receptor as 
shown in Table I. Through the Gs pathway the Gln 
substitution of GluII:10 resulted in a very high 
constitutive signaling corresponding to almost 
40% of Emax of the WT receptor, i.e. similar to 
what was observed with the SerIII:15 to Ala 
mutant (Table I). The high constitutive Gs 
signaling could not be further increased by the 
agonist SP in the GluII:10 to Gln mutant (Table 
I). In respect of Gq signaling, sub-nanomolar 
potency of SP was retained but the Emax was 
reduced to 40% of WT receptor (Table I) and in 
respect of -arrestin mobilization a ten-fold 
reduction in potency of SP was observed while 
the max. signaling efficacy resembled WT 
receptor (Table I). 
It is concluded that GluII:10 very likely in its 
charged form acts as a negative regulator of in 
particular Gs signaling as substitution with Gln 
results in very high constitutive signaling.  
Effect of ‘reintroduction’ of Asp for GluII:10 
on NK1 signaling and Na
+
 modulation 
Mutating GluII:10 (2.50) into aspartic acid, as 
found in the vast majority of 7TM receptors, 
increased cell surface expression by approx. 
50% as compared to wild type receptor (insert in 
Fig. 6a). In contrast to the Ala-substitution, the 
AspII:10 mutant signaled as wild type NK1 
through Gq as determined by IP3-accumulation 
(Fig. 6a). However, in respect of Gs signaling 
the AspII:10 mutant, in contrast to the Ala-
substitution displayed no significant constitutive 
activity in the cAMP assay and had a seriously 
impaired SP-induced cAMP response with  a 
reduction in potency of at least two orders of 
magnitude and not reaching an Emax with the 
highest concentration tested (Fig.6B). In contrast 
to the GluII:10 to Ala mutant, which did show a 
clear but diminished -arrestin response to SP, 
the GluII:10Asp mutant did not recruit -arrestin 
at all upon stimulation with SP (Fig. 6c).  
The most clear allosteric modulatory effect of 
Na+ in receptors with an Asp in position II:10 is 
on ligand binding affinity as recently reported 
for the -opioid receptor (27).  In the wild type 
NK1 receptor no effect of Na+ on SP binding 
was observed in whole cell competition binding 
using radiolabeled SP in transfected COS-7 cells 
(Table II). However, when Asp was 
‘reintroduced instead of Glu in position II:10, 
300mM Na+ impaired the SP affinity from 0.11 
+/-0.05 nM in its absence to 1.2+/-0.5 nM in its 
presence (Table II), i.e. a negative modulating 
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effect similar to what has been reported for the 
-opioid receptor (27). Ala-substitution of 
SerIII:15 (3.39) another residue potentially 
involved in coordinating Na+ in the water 
hydrogen-bond network, had no effect on the 
binding of SP in the NK1 receptor and also here 
no effect on Na+ was observed (Table II). 
Effect of introducing Glu at position II:10 in 
GPR119, B2AR and the Ghrelin receptor 
The B2AR, GPR119 and the Ghrelin receptors 
were chosen because they display variable 
degrees of constitutive activity and all carry an 
Asp in position II:10. Introduction of a Glu 
residue at this position as in the NK1 receptor 
decreased the cell surface expression of all three 
receptors although they were still expressed at 
more than 50% of the corresponding WT 
receptors (Table III). In the case of GPR119 the 
effect of the mutation was difficult to interpret as 
both the constitutive activity and the Emax were 
reduced to approx. 50% of WT, i.e. 
corresponding to the reduction in expression 
level. However, the potency of the agonist 
AR231453 was also reduced, i.e. EC50 increased 
from 2.2 to 17 nM (Table III). In the case of 
B2AR, introduction of Glu at position II:10 
reduced the Emax to 17% of WT and the 
constitutive activity from 9.9 to 2 % (Table III). 
However, the negative effect on signal 
transduction was most clearly observed in the 
ghrelin receptor, where substitution of AspII:10 
with Glu totally eliminated both the constitutive 
signaling and the ghrelin-induced signaling 
(Table III).  
Discussion 
In the present study we tested the unique role of 
GluII:10 (2.50) of the water hydrogen-bond 
network in the NK1 receptor. Molecular 
modeling suggests that the side chain of 
GluII:10 located at a position where almost all 
other Family A GPCRs have an Asp residue, 
replaces one or more water molecules, normally 
found in the inactive conformations of other 
receptors, mediating interactions between the 
conserved polar residues. Consequently GluII:10 
makes direct hydrogen-bond interactions to 
SerIII:15 (3.39) in TM-III and AsnVII:16 (7.49) 
of the NPxxY motif in TM-VII and thereby 
conceivably mimics movable water molecules 
and/or a putative allosteric modulating Na+ ion. 
As previously observed in the B2AR (5), we 
here find that the water-gating residues of the 
hydrogen-bond network are essential for signal 
transduction whereas GluII:10 and its interaction 
partners are important for fine-tuning the 
signaling through Gs versus Gq and -arrestin 
(Fig. 7). 
Is GluII:10 a tethered negative allosteric 
regulator in the NK1 receptor? 
The initial hypothesis was that GluII:10 (2.50), 
by replacing the Na+ ion, would function as a 
tethered negative allosteric modulator and 
account for the unusual lack of constitutive 
signaling by the NK1 receptor. The very high, 
maximal constitutive signaling through Gs 
observed when GluII:10 was substituted with 
Gln, supports this notion (Table I). These data 
also indicate that it is the deprotonated, charged 
form of the -carboxylic acid group of GluII:10 
that acts as an allosteric negative modulator in 
the NK1 receptor in particular of Gs signaling as 
introduction of Gln, which has the same size and 
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similar hydrogen-bond potential as Glu, 
increased the constitutive signaling. 
Surprisingly, however we only observed 
marginal constitutive activity through Gs and no 
constitutive signaling through Gq when GluII:10 
was substituted with Ala (Fig. 3 and 4). One 
explanation could be that GluII:10 not only 
functions as an allosteric negative regulator 
(stabilizing an inactive conformation) but also is 
essential for not only the SP-induced Gq 
signaling, as it clearly is (Fig. 3), but also is 
essential for the ligand-independent, constitutive 
signaling. In other words GluII:10 is also 
involved in stabilizing active conformations of 
the receptor, where it can be replaced by for 
example Gln, but not by Ala. In that case we 
would not be able to observe any high 
constitutive signaling in the Ala substituted 
receptor because the general importance of 
GluII:10 for receptor signaling would prevent 
that. Interestingly, although G-protein signaling 
was eliminated SP-induced arrestin signaling 
was still observed in the GluII:10 to Ala mutant.  
The notion that a Glu residue at position II:10 
(2.50) can act as an allosteric negative regulator 
of receptor signaling was further supported by 
the deleterious effects observed when Glu was 
introduced instead of AspII:10 in the B2AR, 
GPR119 and in particular in the ghrelin receptor, 
where signaling was essentially eliminated.  The 
cell surface expression was somewhat decreased 
in the AspII:10 to Glu mutant form of the 
ghrelin receptor however, we have previously 
studied a number of ghrelin receptor mutants 
having similar or even lower expression levels, 
who nevertheless all signaled efficiently (See 
Table II in (52)).     
Differential Gs versus Gq signaling through 
the water hydrogen-bond network 
Although most 7TM receptors are known to 
signal mainly through one G protein pathway 
they quite often are able to activate several G 
proteins (53-55). The NK1 receptor, for 
example, is best known as a Gq coupled receptor 
activating IP3 and mobilizing calcium. However, 
substance P in fact activates both Gs and Gq
pathways efficiently with similar nanomolar 
potency (38). Interestingly, the mutational 
substitutions of the water hydrogen-bond 
network of the NK1 receptor in several aspects 
affected Gq and Gs signaling differently. Thus 
removal of the polar side-chain of four out of the 
six residues of the water hydrogen-bond network 
individually increased the constitutive, ligand-
independent Gs signaling without affecting the 
corresponding basal Gq signaling (Fig. 4). 
Previously, we have observed a similar 
phenomenon in the B2AR, where Ala-
substitution of AsnI:18, AspII:10 and SerVII:13 
which jointly are coordinating the mobile water 
molecules in this receptor also increased the 
basal, ligand-independent Gs signaling (5). 
The agonist-induced Gs versus Gq signaling was 
also differentially affected by mutational 
substitutions of the hydrogen-bond network. 
Most notably, Ala-substitution of AsnVII:16 
(7.49) of the NPxxY motif selectively eliminated 
Gs signaling with no effect on the Gq pathway. 
The SerVII:12 (7.45) to Ala mutant located one 
helical turn above in TM-VII had a similar 
phenotype but with a somewhat impaired Gq 
response (Fig. 3, 4). Similarly, in the B2AR Ala-
substitution of the corresponding two residues 
both abolished agonist-induced receptor 
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activation through Gs (5). Interestingly, 
molecular modeling studies of the Gs coupled 
TSH receptor suggested that AsnVII:16 (7.49) 
acted as an on/off switch in receptor activation, 
which was confirmed in functional studies as the 
AsnVII:16 to Ala mutant form could not be 
activated by TSH although it bound the agonist 
with wild-type affinity and displayed a normal, 
high constitutive basal Gs signaling (56). In the 
CCK receptor, the AsnVII:16 (7.49) residue has 
been demonstrated to be essential for Gq
signaling (57). Apparently the interface between 
TM-II, TM-III, and TM-VII is particular 
important for Gs versus Gq signaling. 
Previously, we identified another residue located 
at this interface but more towards the 
extracellular side between TM-II and TM-III, i.e.
PheIII:07 (3.31) which upon substitution to Ser 
also selectively uncoupled the NK1 receptor 
from the Gs pathway while leaving Gq signaling 
intact (38).  
-Arrestin versus G protein signaling through 
the water hydrogen-bond network 
Both ligands and mutations have been shown to 
be able to stabilize distinct conformations 
leading to biased receptor signaling within 
specific GPCRs (4,38,58-62). As shown in Fig. 
7, we here find that mutations of GluII:10 and 
AsnVII:16, which according to the molecular 
modeling in the NK1 receptor are interacting 
directly with each other, result in biased 
signaling, i.e. where the three signaling 
pathways Gs, Gq and -arrestin mobilization are 
differentially affected. Thus, in the AsnVII:16 to 
Ala mutant the Gs signaling was selectively 
eliminated while both Gq signaling and -
arrestin mobilization were similar to wild type 
NK1. In contrast, in the GluII:10 (2.50) to Ala 
mutant both SP-induced Gq and Gs signaling 
were totally eliminated while the SP-induced 
recruitment of -arrestin was rather well 
preserved in particular when taking into account 
the somewhat reduced cell surface expression 
(Fig. 5). Thus, removal of the acidic side-chain 
of GluII:10 by Ala-substitution converted the 
NK1 receptor into a clean -arrestin-biased 
receptor. However, when GluII:10 instead was 
substituted with the shorter acidic Asp residue - 
as found in most other receptors – -arrestin 
mobilization was totally eliminated and Gs 
signaling seriously impaired while Gq signaling 
was similar to wild type NK1 (Fig. 6). This 
underlines the crucial importance of the water 
hydrogen-bond network for fine-tuning the 
signaling of in this case the NK1 receptor 
through different signal transduction pathways 
(Fig. 7).  
Interestingly, an interaction between AspII:10 
(2.50) and AsnVII:16 (7.49) of the NPxxY motif 
in TM-VII was early on proposed in several 
receptors based on observations that paired swap 
of these two residues could restore receptor 
signaling, compared to the detrimental effects of 
each of the single mutations (50,63-65). 
Furthermore, rearrangements in this region 
during activation have also been shown for 
rhodopsin using radiolytic protein footprinting 
(66).  
The water-gating residues of the hydrogen-
bond network are essential for signaling in 
general   
Three residues appeared to be essential for all 
three signaling pathways Gq, Gs and -arrestin 
mobilization: the two water-gating micro-switch 
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residues, TrpVI:13 (6.48) and TyrVII:20 (7.53) 
and the totally conserved AsnI:18 (1.50) (Fig. 7). 
Originally we demonstrated by molecular 
dynamics simulations based on the high 
resolution structures of rhodopsin and B2AR 
that most of the water molecules of the network 
are highly mobile and that the entry and exit of 
these waters in and out of the network is gated 
by micro-switch residues, i.e. towards the 
ligand-binding pocket by TrpVI:13 and towards 
the intracellular cytosol by the rotary micro-
switch TyrVII:20 (see central vignette in Figs 3-
5) (5). Structures of active receptor 
conformations subsequently demonstrated that 
the ‘water volume’ of the hydrogen-bond 
network changes considerably in the transition 
between inactive and active conformations in 
which most of the water molecules are 
‘squeezed’ out (16,27). Thus, the movement of 
water molecules in and out of the network and 
the gating of these must be essential for receptor 
function (5). Accordingly, in the present study of 
the NK1 receptor we find that both of the ‘water 
gating’ residues, TrpVI:13 and TyrVII:20 are 
essential for all three signaling pathways tested, 
just as we found they were essential for the Gs 
signaling in the B2AR (5). TrpVI:13 has been 
extensively studied and determined to be 
essential for receptor activation in multiple 7TM 
receptors (46). The rotameric micro-switch, 
TyrVII:20 in its inward rotameric form stabilizes 
the outward tilt of TM-VI (2), which opens a 
pocket between the helices allowing for G 
protein binding (29,67-70).
AsnI:18 (1.50), which in the inactive receptor 
conformation makes a helix kink-stabilizing 
hydrogen-bond to the backbone carbonyl of the 
residue in position VII:13 (7.46) exposed by the 
highly conserved ProVII:17 (7.50) of the NPxxY 
motif, is the only residue which is totally 
conserved throughout the entire, large 
rhodopsin-like family A of 7TM receptors (42). 
In the NK1 receptor the AsnI:18 (1.50) to Ala 
mutant abolished all receptor signaling. The 
extraordinary conservation of this residue in 
7TM receptors would suggests that it is essential 
in receptor signaling in general. However, in the 
B2AR we found that the corresponding AsnI:18 
to Ala substitution surprisingly had no effect on 
the agonist induced Gs signaling and in fact 
increased the constitutive activity (5).  
In conclusion – Based on the X-ray structures, 
molecular dynamics simulations and mutational 
analysis we have previously proposed that the 
extended water hydrogen-bond network between  
TM-I, -II, -III, -VI and -VII constitutes an 
allosteric interface essential for stabilizing 
different active and inactive helical 
constellations during receptor activation (5). 
Here, we confirm that the water-gating micro-
switch residues TrpVI:13 (6.48) of the CWxP 
motif and TyrVII:20 (7.53) of the NPxxY motif 
are essential for all signaling also in the NK1 
receptor. Importantly, we identify the interaction 
between the unique Glu in position II:10 (2.50), 
SerIII:15 (3.39) and AsnVII:16 (7.49) of the 
NPxxY motif in TM-VII as a key point for 
determiningGs versus Gq signaling as well as 
-arrestin mobilization. Specifically the interface 
between TM-II, -III and –VII appears to be 
particular important for Gs signaling which 
could potentially be used in future drug 
discovery efforts. For example, it may be 
possible to generate agonists with an appropriate 
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signaling bias ensuring proper balance in 
efficacy through the Gs and the Gq pathways as 
recently described for the long chain fatty acid 
receptor GPR40 to obtain appropriate in vivo 
incretin releasing efficacy (71).  
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actual location of the residues in each trans-membrane helix, is used throughout the article (41) 
Figure legends 
Figure 1. Structural conservation of the polar interface between TM-I, -II, -III and –VII. Panel 
A-Structural distribution of conserved polar residues between the intracellular half of TM-I, -II, -III, 
and -VII of 18 unique inactive GPCR structures. The residues AsnI:18, (1.50), AspII:10 (2.50), 
SerIII:15 (3.39), SerVII:12 (7.45), ThrVII:13 (7.46) and AsnVII:16 (7.49) of the conserved polar 
interface restricted by the functional important and conserved TrpVI:13 (6.48) and TyrVII:20 (7.53) 
in the antagonist bound structures of A2AAR (PDBID:4EIY solved at 1.8 Å resolution)  (blue), B2AR 
(PDBID: 2RH1) (yellow) are shown in sticks. The corresponding residues in the other inactive 
structures are shown by grey lines. Panel B-Close-up view of the polar interface comprising a sodium 
ion (purple sphere) and water molecules (red spheres). Co-localized water molecules in the A2AAR 
and the B2AR structure are shown as yellow spheres. The salt-bridge between sodium and AspII:10 
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(2.50) and water mediated hydrogen bond interactions are shown as grey dotted lines. Panel C- Close-
up view of the polar pocket in the active-like agonist bound A2AAR/UK432,097 structure (PDBID: 
3QAK) (blue) and the active agonist bound B2AR structure in complex with Gs (PDBID: 3SN6). 
Panel D-Polar pocket alignment of the distinct inactive experimental structures compared to the 
conforming sequence in the NK1 receptor, which have a Glutamic acid instead of the highly 
conserved AspII:10 (2.50). Panel E-F-Structural details of AspII:10 Glu substitution (green) in the 
inactive A2AAR structure (E, First rotamer conformation of AspII:10 Glu substitution, F, Second 
rotamer conformation of AspII:10 Glu substitution). Water molecules that make steric clashes with 
the substituted Glutamic acid are shown as big transparent spheres. 
Figure 2. NK1 receptor models Panel A- Side and top close-up view of the conserved polar interface 
including AsnI:18 (1.50), GluII:10 (2.50), SerIII:15 (3.39), SerVII:12 (7.45), ThrVII:13 (7.46) and 
AsnVII:16 (7.49) in the inactive NK1 receptor model restricted by the functional important and 
conserved residues TrpVI:13 (6.48) and TyrVII:20 (7.53). Water molecules are shown as red spheres 
and hydrogen bonds in grey dotted lines. In contrast to highly conserved AspII:10, the longer GluII:10
side-chain in the NK1 model is predicted to make direct, rather than water mediated interactions with 
SerIII:15 and AsnVII:16. Dashed red arrows shows the conformational rearrangements of TM-II, -III 
and -VII (illustrated by light green and transparent circles) required to obtain an “active” NK1 
receptor structure consistent with common conformational changes observed in distinct active 
structures. Panel B-Model of the conserved polar interface of the NK1 receptor in an “active” state, 
based on the agonist-bound A2AAR structure (PDBID: 3QAK). 
Figure 3. Functional consequence of Ala substitution on Gq signaling of the conserved polar 
residues in the NK1 receptor Panel a- Structure of the hydrogen bond network in the NK1 receptor 
model based on A2AAR (PDBID: 4EIY) as a template structure. Key side-chains are shown in sticks 
and water molecules as red spheres. Panel b-h- Agonist (SP)-induced IP3 production in COS-7 cells 
transiently transfected with either wild-type NK1 (dotted lines) or mutant forms of ThrVII:13Ala 
(7.46) (b), GluII:10Ala (2.50) (c), AsnI:18Ala (1.50) (d), SerIII:15Ala (3.39) (e), SerVII:12Ala (7.45) 
(f), AsnVII:16Ala (7.49) (g), TrpVI:13Ala (6.48) (h) and TyrVII:20Ala (7.53) (i). Cell surface 
receptor expression measured by ELISA is shown in the inserted column diagrams in each panel.
Figure 4. Functional consequence of Ala substitution on Gs signaling of the conserved polar 
residues in the NK1 receptor Panel a- Structure of the hydrogen bond network in the NK1 receptor 
model based on A2AAR (PDBID: 4EIY) as a template structure. Key side-chains are shown in sticks 
and water molecules as red spheres. Panel b-h- Agonist (SP)-induced cAMP production in COS-7 
cells transiently transfected with either wild-type NK1 (dotted lines) or mutant forms of ThrVII:13Ala 
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(7.46) (b), GluII:10Ala (2.50) (c), AsnI:18Ala (1.50) (d), SerIII:15Ala (3.39) (e), SerVII:12Ala (7.45) 
(f), AsnVII:16Ala (7.49) (g), TrpVI:13Ala (6.48) (h) and TyrVII:20Ala (7.53) (i).
Figure 5. Functional consequence of Ala substitution on -Arrestin2 mobilization of the 
conserved polar residues in the NK1 receptor Panel a- Structure of the hydrogen bond network in 
the NK1 receptor model based on A2AAR (PDBID: 4EIY)  as a template structure. Key side-chains 
are shown in sticks and water molecules as red spheres. Panel b-h- Agonist (SP)-induced -Arrestin2
mobilization in CHOK1 cells transiently transfected with either wild-type NK1 (dotted lines) or 
mutant forms of ThrVII:13Ala (7.46) (b), GluII:10Ala (2.50) (c), AsnI:18Ala (1.50) (d), SerIII:15Ala 
(3.39) (e), SerVII:12Ala (7.45) (f), AsnVII:16Ala (7.49) (g), TrpVI:13Ala (6.48) (h) and 
TyrVII:20Ala (7.53) (i).
Figure 6. Functional consequence of Asp substitution of the GluII:10 (2.50) residue in the NK1 
receptor Panel a-c- Agonist (SP)-induced IP3 (b), cAMP (c) or -Arrestin2 (d) mobilization in COS-7 
cells (IP3 and cAMP) or CHOK1 cells (-Arrestin2) transiently transfected with either wild-type NK1 
(dotted lines) or mutant GluII:10Ala/Asp. Cell surface receptor expression measured by ELISA is 
shown in the inserted column diagram in the panel b.
Figure 7. Residues of the water hydrogen-bond network of the NK1 receptor identified to be 
either essential for overall signal transduction or for the fine-tuning and bias of signaling 
through the three different signaling pathways: Gs, Gq and -arrestin. Three resides were by 
Ala-substitutions identified to be essential for all three signal transduction pathways: the water-gating 
TrpVI:13 (6.48) of the CWxP motif and the TyrVII:20 (7.53) of the NPxxY motif as well as the ultra-
highly conserved, TM-VII kink-stabilizing AsnI:18 (1.50). Mutations of GluII:10 (2.50), which in the 
NK1 receptor uniquely replaces the otherwise highly conserved AspII:10, and the two residues, which 
it according to the molecular models, makes direct hydrogen bond interactions with, SerIII:15 (3.39) 
and AsnVII:16 (7.49) creates receptor mutants with biased signaling though: -arrestin only (GluII:10 
to Ala), Gq only (GluII:10 to Asp), high constitutive Gs signaling (GluII:10 to Gln) and Gq plus -
arrestin but not Gs (AsnVII:16 to Ala). Ala-substitution of SerIII:15 selectively increases Gs signaling 
from zero to approx. 40% of Emax.    
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